Lyka Labs Inks out-licensing Deal WWith US Based Generics Firm

Subscribe to GoodReturns

Lyka Labs said that it has entered into out-licensing / technology transfer deal with a US based Generics Company.

Lyka Labs Inks out-licensing Deal WWith US Based Generics Firm
"It has entered an out-licensing / technology transfer deal for a basket of 12 Sterile Injectable Formulations for Manufacturing, Sales & Distribution in the United State of America," the company said in a filing to the Bombay Stock Exchange.

The market size of the licensed formulations is approximately USD 1.4 billion, as per IMS MAT March 2017.

The company will be eligible for a royalty on end sales, filing added.

Going forward, the company will continue to explore opportunities to monetize its R&D capabilities in the regulated markets throughout-licensing partnerships.

Meanwhile, shares of the company were trading at Rs 52 apiece, up 2.97 per cent from the previous close at 11:18 hours on BSE.

Read more about: lyka labs
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Find IFSC